- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04833010
Effects of Face Masks During Exercise
January 20, 2025 updated by: Simon Driver, Baylor Research Institute
Effects of Face Coverings During Physical Activity
To describe the primary and secondary outcomes of athletes during a Cardiopulmonary Exercise Test (CPET) on a cycle ergometer with and without a face mask.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Frisco, Texas, United States, 75034
- Baylor Scott & White Sports Therapy & Research at The Star
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Be able to come to Baylor Scott & White Sports Therapy and Research at The Star in Frisco, Texas twice in three weeks.
- Be willing to wear a face mask during exercise capacity testing on a stationary bicycle.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: No cloth face mask
Cross-over randomization.
Participants randomized to this arm will not wear a cloth face mask for Test 1 which they do a progressive step-exercise cycling test to exhaustion
|
Participants will complete a Cardiopulmonary Exercise test on cycle ergometer in which they will perform progressive step-exercise cycling to exhaustion
Cognitive Performance will be tested using a cognition application on an iPad during the Cardiopulmonary Exercise Test.
|
|
Experimental: Cloth face mask
Cross-over randomization.
Participants randomized to this arm will wear a cloth face mask for Test 1 which they do a progressive step-exercise cycling test to exhaustion
|
Participants will complete a Cardiopulmonary Exercise test on cycle ergometer in which they will perform progressive step-exercise cycling to exhaustion
Cognitive Performance will be tested using a cognition application on an iPad during the Cardiopulmonary Exercise Test.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VO2 max during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
|
Exercise capacity measured by Cosmed K5 metabolic equipment
|
Week 1
|
|
VO2 max during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
|
Exercise capacity measured by Cosmed K5 metabolic equipment
|
Week 2
|
|
Test duration (time) of cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
|
Total time of test
|
Week 1
|
|
Test duration (time) of cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
|
Total time of test
|
Week 2
|
|
Reaction time of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
|
Cognitive testing will take place at the end of each stage of the CPET.
Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET.
The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored.
SRT will then be administered for 30s at the end of each stage of the CPET.
The SRT task includes a visual stimulus presented on the touchscreen.
Subjects will be instructed to press the stimulus on-screen as quickly as possible.
Reaction time will be measured on the SRT task.
Reaction time is calculated as the average amount of time in seconds between stimulus presentation and user response within a session.
|
Week 1
|
|
Reaction time of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
|
Cognitive testing will take place at the end of each stage of the CPET.
Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET.
The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored.
SRT will then be administered for 30s at the end of each stage of the CPET.
The SRT task includes a visual stimulus presented on the touchscreen.
Subjects will be instructed to press the stimulus on-screen as quickly as possible.
Reaction time will be measured on the SRT task.
Reaction time is calculated as the average amount of time in seconds between stimulus presentation and user response within a session.
|
Week 2
|
|
Accuracy of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
|
Cognitive testing will take place at the end of each stage of the CPET.
Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET.
The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored.
SRT will then be administered for 30s at the end of each stage of the CPET.
The SRT task includes a visual stimulus presented on the touchscreen.
Subjects will be instructed to press the stimulus on-screen as quickly as possible.
Accuracy will be measured on the SRT task.
Accuracy is calculated as the total number of correct responses to stimuli divided by the total number of stimuli presented during a session (presented as a percentage).
|
Week 1
|
|
Accuracy of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
|
Cognitive testing will take place at the end of each stage of the CPET.
Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET.
The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored.
SRT will then be administered for 30s at the end of each stage of the CPET.
The SRT task includes a visual stimulus presented on the touchscreen.
Subjects will be instructed to press the stimulus on-screen as quickly as possible.
Accuracy will be measured on the SRT task.
Accuracy is calculated as the total number of correct responses to stimuli divided by the total number of stimuli presented during a session (presented as a percentage).
|
Week 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective dyspnea rating during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
|
The Modified Borg Dyspnea Scale (0-10) will be used to assess subjective shortness of breath.
Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer.
|
Week 1
|
|
Subjective dyspnea rating during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
|
The Modified Borg Dyspnea Scale (0-10) will be used to assess subjective shortness of breath.
Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer.
|
Week 2
|
|
Ratings of perceived exertion during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
|
The Borg Rating of Perceived Exertion (6-20) scale will be used during the test to assess subjective exertion.
Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer
|
Week 1
|
|
Ratings of perceived exertion during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
|
The Borg Rating of Perceived Exertion (6-20) scale will be used during the test to assess subjective exertion.
Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer
|
Week 2
|
|
Oxygen saturation during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
|
Measured by a pulse oximeter during each stage of the exercise protocol of the cardiopulmonary exercise test on a cycle ergometer
|
Week 1
|
|
Oxygen saturation during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
|
Measured by a pulse oximeter during each stage of the exercise protocol of the cardiopulmonary exercise test on a cycle ergometer
|
Week 2
|
|
Blood lactate during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
|
Blood lactate will be measured pre and post-CPET using a Nova Medical Lactate Plus: Blood Lactate Measuring Meter-Version 2 device.
|
Week 1
|
|
Blood lactate during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
|
Blood lactate will be measured pre and post-CPET using a Nova Medical Lactate Plus: Blood Lactate Measuring Meter-Version 2 device.
|
Week 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2021
Primary Completion (Actual)
July 1, 2021
Study Completion (Actual)
July 15, 2021
Study Registration Dates
First Submitted
February 9, 2021
First Submitted That Met QC Criteria
April 2, 2021
First Posted (Actual)
April 6, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 20, 2025
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 020-353
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Considered upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on Cardiopulmonary Exercise Test
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
University of HullSheffield Hallam UniversityTerminated
-
Virginia Commonwealth UniversityNovartis PharmaceuticalsCompletedPrior Acute Myocardial Infarction | Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) | Reduced Left Ventricle Ejection Fraction (<50%) | Symptoms of Heart Failure (NYHA Class II-III)United States
-
The Clatterbridge Cancer Centre NHS Foundation...University of Liverpool Cancer Research CentreNot yet recruiting
-
York Teaching Hospitals NHS Foundation TrustUniversity of York; York St John UniversityCompletedInflammatory Response | Immune SystemUnited Kingdom
-
Bezmialem Vakif UniversityCompleted
-
Chang Gung Memorial HospitalCompletedComorbid Chronic Lung Disease on Heart Failure
-
Hasselt UniversityCompletedCoronary Artery Bypass SurgeryBelgium
-
Wissenschaftliches Institut Bethanien e.VRoche Pharma AGCompleted
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous MalformationsUnited Kingdom